8 September 2020 · NICE guidance providing good practice recommendations for individual people and organisations involved with the development, authorisation and use PGDs.
8 September 2020 · This Q&A outlines the advice on the use of PGDs by registered healthcare professionals who are undertaking training and/or competency assessment.
10 June 2020 · The following Q&A is intended to be read as a complete document to help provide the full context in practice. In this document the term…
8 January 2020 · The below summary details the legal position regarding the sale, supply or administration of off-label/ unlicenced products under Schedule 17 of the HMR 2012
28 November 2019 · This updated Medicines Q&A aims to explain the legal status of medicines in the UK and when and how they may be supplied by dentists…
11 November 2019 · This document has been developed by the NHS Quality Assurance Committee and National Pharmacy Clinical Trials Advisory Group with input provided by the MHRA Clinical…
27 September 2019 · Regulatory export requirements for hospitals procuring (harvesting) patient’s own cells/tissues for use as starting materials in the manufacture of ATMPs.
18 September 2019 · This document aims to provide guidance to NHS Chief Pharmacists and Accountable Pharmacists working under the Section 10 exemption to the Medicines Act 1968 on…
3 September 2019 · The NHS Aseptic Services Accreditation Working Group, working closely with the South West Product Approval Accreditation Programme have developed and published a definition of Supervision…
2 April 2019 · This document provides guidance and advice which is still relevant to the NHS today, on the application of the licensing provisions of the Medicines Act…